MR imaging of renal collecting system with gadoxetate disodium: Feasibility for MR urography

R. Joshua Dym, Victoria Chernyak, Alla Rozenblit

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose To determine the feasibility of using gadoxetate disodium for MR urography. Materials and Methods We retrospectively reviewed 50 consecutive gadoxetate disodium-enhanced abdominal MRI examinations meeting inclusion criteria. For each examination, 30 min postcontrast hepatobiliary phase sequences were reviewed to assess bilateral collecting system segments, including upper pole, interpolar, and lower pole calyces; renal pelvis; and proximal one-third of ureter. Each segment was assessed for degree of opacification (none, <50%, ≥50%, complete) and susceptibility artifact (none, partial thin rim, thick/complete rim, total obscuration). Opacification and susceptibility scores were also calculated for each examination. Results The 50 reviewed examinations were performed on 46 patients (26 women, 20 men; mean age, 57 years) and included a total of 1000 segments. Of these, 808 (80.8%) were opacified completely, 103 (10.3%) were opacified ≥50%, 39 (3.9%) were opacified <50%, and 50 (5.0%) were not opacified. Of 1000 segments, no susceptibility artifact was present in 822 (82.2%), while a partial thin rim was present in 113 (11.3%), a thick/complete rim in 64 (6.4%) and total obscuration in 1 (0.1%). Conclusion Gadoxetate disodium contrast produced a high degree of opacification of the proximal urinary collecting system with low incidence of susceptibility artifact; therefore, it is a feasible contrast agent for MR urography.

Original languageEnglish (US)
Pages (from-to)816-823
Number of pages8
JournalJournal of Magnetic Resonance Imaging
Volume38
Issue number4
DOIs
StatePublished - Oct 2013

Fingerprint

Urography
Artifacts
Kidney
Kidney Pelvis
Ureter
Contrast Media
Incidence
gadolinium ethoxybenzyl DTPA

Keywords

  • gadoxetate disodium
  • Gd-EOB-DTPA
  • MR urography
  • MRI
  • urinary tract imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

MR imaging of renal collecting system with gadoxetate disodium : Feasibility for MR urography. / Dym, R. Joshua; Chernyak, Victoria; Rozenblit, Alla.

In: Journal of Magnetic Resonance Imaging, Vol. 38, No. 4, 10.2013, p. 816-823.

Research output: Contribution to journalArticle

@article{02682ada0e2149ab8022466281c7bbb8,
title = "MR imaging of renal collecting system with gadoxetate disodium: Feasibility for MR urography",
abstract = "Purpose To determine the feasibility of using gadoxetate disodium for MR urography. Materials and Methods We retrospectively reviewed 50 consecutive gadoxetate disodium-enhanced abdominal MRI examinations meeting inclusion criteria. For each examination, 30 min postcontrast hepatobiliary phase sequences were reviewed to assess bilateral collecting system segments, including upper pole, interpolar, and lower pole calyces; renal pelvis; and proximal one-third of ureter. Each segment was assessed for degree of opacification (none, <50{\%}, ≥50{\%}, complete) and susceptibility artifact (none, partial thin rim, thick/complete rim, total obscuration). Opacification and susceptibility scores were also calculated for each examination. Results The 50 reviewed examinations were performed on 46 patients (26 women, 20 men; mean age, 57 years) and included a total of 1000 segments. Of these, 808 (80.8{\%}) were opacified completely, 103 (10.3{\%}) were opacified ≥50{\%}, 39 (3.9{\%}) were opacified <50{\%}, and 50 (5.0{\%}) were not opacified. Of 1000 segments, no susceptibility artifact was present in 822 (82.2{\%}), while a partial thin rim was present in 113 (11.3{\%}), a thick/complete rim in 64 (6.4{\%}) and total obscuration in 1 (0.1{\%}). Conclusion Gadoxetate disodium contrast produced a high degree of opacification of the proximal urinary collecting system with low incidence of susceptibility artifact; therefore, it is a feasible contrast agent for MR urography.",
keywords = "gadoxetate disodium, Gd-EOB-DTPA, MR urography, MRI, urinary tract imaging",
author = "Dym, {R. Joshua} and Victoria Chernyak and Alla Rozenblit",
year = "2013",
month = "10",
doi = "10.1002/jmri.24059",
language = "English (US)",
volume = "38",
pages = "816--823",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - MR imaging of renal collecting system with gadoxetate disodium

T2 - Feasibility for MR urography

AU - Dym, R. Joshua

AU - Chernyak, Victoria

AU - Rozenblit, Alla

PY - 2013/10

Y1 - 2013/10

N2 - Purpose To determine the feasibility of using gadoxetate disodium for MR urography. Materials and Methods We retrospectively reviewed 50 consecutive gadoxetate disodium-enhanced abdominal MRI examinations meeting inclusion criteria. For each examination, 30 min postcontrast hepatobiliary phase sequences were reviewed to assess bilateral collecting system segments, including upper pole, interpolar, and lower pole calyces; renal pelvis; and proximal one-third of ureter. Each segment was assessed for degree of opacification (none, <50%, ≥50%, complete) and susceptibility artifact (none, partial thin rim, thick/complete rim, total obscuration). Opacification and susceptibility scores were also calculated for each examination. Results The 50 reviewed examinations were performed on 46 patients (26 women, 20 men; mean age, 57 years) and included a total of 1000 segments. Of these, 808 (80.8%) were opacified completely, 103 (10.3%) were opacified ≥50%, 39 (3.9%) were opacified <50%, and 50 (5.0%) were not opacified. Of 1000 segments, no susceptibility artifact was present in 822 (82.2%), while a partial thin rim was present in 113 (11.3%), a thick/complete rim in 64 (6.4%) and total obscuration in 1 (0.1%). Conclusion Gadoxetate disodium contrast produced a high degree of opacification of the proximal urinary collecting system with low incidence of susceptibility artifact; therefore, it is a feasible contrast agent for MR urography.

AB - Purpose To determine the feasibility of using gadoxetate disodium for MR urography. Materials and Methods We retrospectively reviewed 50 consecutive gadoxetate disodium-enhanced abdominal MRI examinations meeting inclusion criteria. For each examination, 30 min postcontrast hepatobiliary phase sequences were reviewed to assess bilateral collecting system segments, including upper pole, interpolar, and lower pole calyces; renal pelvis; and proximal one-third of ureter. Each segment was assessed for degree of opacification (none, <50%, ≥50%, complete) and susceptibility artifact (none, partial thin rim, thick/complete rim, total obscuration). Opacification and susceptibility scores were also calculated for each examination. Results The 50 reviewed examinations were performed on 46 patients (26 women, 20 men; mean age, 57 years) and included a total of 1000 segments. Of these, 808 (80.8%) were opacified completely, 103 (10.3%) were opacified ≥50%, 39 (3.9%) were opacified <50%, and 50 (5.0%) were not opacified. Of 1000 segments, no susceptibility artifact was present in 822 (82.2%), while a partial thin rim was present in 113 (11.3%), a thick/complete rim in 64 (6.4%) and total obscuration in 1 (0.1%). Conclusion Gadoxetate disodium contrast produced a high degree of opacification of the proximal urinary collecting system with low incidence of susceptibility artifact; therefore, it is a feasible contrast agent for MR urography.

KW - gadoxetate disodium

KW - Gd-EOB-DTPA

KW - MR urography

KW - MRI

KW - urinary tract imaging

UR - http://www.scopus.com/inward/record.url?scp=84886923019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886923019&partnerID=8YFLogxK

U2 - 10.1002/jmri.24059

DO - 10.1002/jmri.24059

M3 - Article

C2 - 23408536

AN - SCOPUS:84886923019

VL - 38

SP - 816

EP - 823

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 4

ER -